Funder
Myers-JDC-Brookdale Institute
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference23 articles.
1. Morel, T., Arickx, F., Befrits, G., Siviero, P., van der Meijden, C., Xoxi, E., Simoens, S.: Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries. Orphanet J. Rare Dis. 8(1), 198 (2013)
2. Carlson, J.J., Sullivan, S.D., Garrison, L.P., Neumann, P.J., Veenstra, D.L.: Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy 96(3), 179–190 (2010)
3. Cook, J.P., Vernon, J.A., Manning, R.: Pharmaceutical risk-sharing agreements. Pharmacoeconomics 26(7), 551–556 (2008)
4. Vogler, S., Paris, V., Panteli, D.: Ensuring Access to Medicines: How to Redesign Pricing, Reimbursement and Procurement? World Health Organization, Regional Office for Europe (2018)
5. Ferrario, A., Kanavos, P.: Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Soc. Sci. Med. 124, 39–47 (2015)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献